Annual D&A
$1.23 M
+$414.00 K+50.80%
December 31, 2024
Summary
- As of March 13, 2025, KROS annual depreciation & amortization is $1.23 million, with the most recent change of +$414.00 thousand (+50.80%) on December 31, 2024.
- During the last 3 years, KROS annual D&A has risen by +$851.00 thousand (+225.13%).
- KROS annual D&A is now at all-time high.
Performance
KROS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$332.00 K
+$18.00 K+5.73%
December 31, 2024
Summary
- As of March 13, 2025, KROS quarterly depreciation & amortization is $332.00 thousand, with the most recent change of +$18.00 thousand (+5.73%) on December 31, 2024.
- Over the past year, KROS quarterly D&A has stayed the same.
- KROS quarterly D&A is now at all-time high.
Performance
KROS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.23 M
+$85.00 K+7.43%
December 31, 2024
Summary
- As of March 13, 2025, KROS TTM depreciation & amortization is $1.23 million, with the most recent change of +$85.00 thousand (+7.43%) on December 31, 2024.
- Over the past year, KROS TTM D&A has stayed the same.
- KROS TTM D&A is now at all-time high.
Performance
KROS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
KROS Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.8% | 0.0% | 0.0% |
| 3 y3 years | +225.1% | +219.2% | +225.1% |
| 5 y5 years | +490.9% | +462.7% | +490.9% |
KROS Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +225.1% | at high | +219.2% | at high | +225.1% |
| 5 y | 5-year | at high | +490.9% | at high | +462.7% | at high | +490.9% |
| alltime | all time | at high | +703.3% | at high | +637.8% | at high | +2631.1% |
Keros Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.23 M(+50.8%) | $332.00 K(+5.7%) | $1.23 M(+7.4%) |
| Sep 2024 | - | $314.00 K(+2.6%) | $1.14 M(+10.0%) |
| Jun 2024 | - | $306.00 K(+10.5%) | $1.04 M(+12.4%) |
| Mar 2024 | - | $277.00 K(+12.1%) | $925.00 K(+13.5%) |
| Dec 2023 | $815.00 K(+20.9%) | $247.00 K(+17.6%) | $815.00 K(+17.3%) |
| Sep 2023 | - | $210.00 K(+9.9%) | $695.00 K(+13.7%) |
| Jun 2023 | - | $191.00 K(+14.4%) | $611.00 K(-16.1%) |
| Mar 2023 | - | $167.00 K(+31.5%) | $728.00 K(+8.0%) |
| Dec 2022 | $674.00 K(+78.3%) | $127.00 K(+0.8%) | $674.00 K(+3.5%) |
| Sep 2022 | - | $126.00 K(-59.1%) | $651.00 K(+3.7%) |
| Jun 2022 | - | $308.00 K(+172.6%) | $628.00 K(+52.8%) |
| Mar 2022 | - | $113.00 K(+8.7%) | $411.00 K(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $378.00 K(+36.0%) | $104.00 K(+1.0%) | $378.00 K(+8.3%) |
| Sep 2021 | - | $103.00 K(+13.2%) | $349.00 K(+9.7%) |
| Jun 2021 | - | $91.00 K(+13.8%) | $318.00 K(+7.8%) |
| Mar 2021 | - | $80.00 K(+6.7%) | $295.00 K(+6.1%) |
| Dec 2020 | $278.00 K(+33.7%) | $75.00 K(+4.2%) | $278.00 K(+6.1%) |
| Sep 2020 | - | $72.00 K(+5.9%) | $262.00 K(+6.9%) |
| Jun 2020 | - | $68.00 K(+7.9%) | $245.00 K(+8.4%) |
| Mar 2020 | - | $63.00 K(+6.8%) | $226.00 K(+8.7%) |
| Dec 2019 | $208.00 K(+35.9%) | $59.00 K(+7.3%) | $208.00 K(+39.6%) |
| Sep 2019 | - | $55.00 K(+12.2%) | $149.00 K(+58.5%) |
| Jun 2019 | - | $49.00 K(+8.9%) | $94.00 K(+108.9%) |
| Mar 2019 | - | $45.00 K | $45.00 K |
| Dec 2018 | $153.00 K | - | - |
FAQ
- What is Keros Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Keros Therapeutics?
- What is Keros Therapeutics annual D&A year-on-year change?
- What is Keros Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Keros Therapeutics?
- What is Keros Therapeutics quarterly D&A year-on-year change?
- What is Keros Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Keros Therapeutics?
- What is Keros Therapeutics TTM D&A year-on-year change?
What is Keros Therapeutics annual depreciation & amortization?
The current annual D&A of KROS is $1.23 M
What is the all time high annual D&A for Keros Therapeutics?
Keros Therapeutics all-time high annual depreciation & amortization is $1.23 M
What is Keros Therapeutics annual D&A year-on-year change?
Over the past year, KROS annual depreciation & amortization has changed by +$414.00 K (+50.80%)
What is Keros Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of KROS is $332.00 K
What is the all time high quarterly D&A for Keros Therapeutics?
Keros Therapeutics all-time high quarterly depreciation & amortization is $332.00 K
What is Keros Therapeutics quarterly D&A year-on-year change?
Over the past year, KROS quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Keros Therapeutics TTM depreciation & amortization?
The current TTM D&A of KROS is $1.23 M
What is the all time high TTM D&A for Keros Therapeutics?
Keros Therapeutics all-time high TTM depreciation & amortization is $1.23 M
What is Keros Therapeutics TTM D&A year-on-year change?
Over the past year, KROS TTM depreciation & amortization has changed by $0.00 (0.00%)